Cargando…
SREBP2 regulates the endothelial response to cytokines via direct transcriptional activation of KLF6
The transcription factor SREBP2 is the main regulator of cholesterol homeostasis and is central to the mechanism of action of lipid-lowering drugs, such as statins, which are responsible for the largest overall reduction in cardiovascular risk and mortality in humans with atherosclerotic disease. Re...
Autores principales: | Fowler, Joseph Wayne M., Boutagy, Nabil E., Zhang, Rong, Horikami, Daiki, Whalen, Michael B., Romanoski, Casey E., Sessa, William C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407908/ https://www.ncbi.nlm.nih.gov/pubmed/37437844 http://dx.doi.org/10.1016/j.jlr.2023.100411 |
Ejemplares similares
-
Inflammatory stress signaling via NF-kB alters accessible cholesterol to upregulate SREBP2 transcriptional activity in endothelial cells
por: Fowler, Joseph Wayne M, et al.
Publicado: (2022) -
Cholesterol synthesis enzyme SC4MOL is fine-tuned by sterols and targeted for degradation by the E3 ligase MARCHF6
por: Qian, Lydia, et al.
Publicado: (2023) -
TMEM241 is a UDP-N-acetylglucosamine transporter required for M6P modification of NPC2 and cholesterol transport
por: Zhao, Nan, et al.
Publicado: (2023) -
Correlation between small and dense low‐density lipoprotein cholesterol and cardiovascular events in Beijing community population
por: Wang, Xiaona, et al.
Publicado: (2021) -
Role of KLF15 in Regulation of Hepatic Gluconeogenesis and Metformin Action
por: Takashima, Mototsugu, et al.
Publicado: (2010)